These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

879 related items for PubMed ID: 27567693

  • 21. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
    Wisse PHA, de Klaver W, van Wifferen F, Meiqari L, Bierkens M, Greuter MJE, Carvalho B, van Leerdam ME, Spaander MCW, Dekker E, Coupé VMH, de Wit M, Meijer GA.
    BMC Cancer; 2022 Dec 12; 22(1):1299. PubMed ID: 36503495
    [Abstract] [Full Text] [Related]

  • 22. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.
    Vasilyev S, Smirnova E, Popov D, Semenov A, Eklund C, Hendolin P, Paloheimo L, Syrjänen K.
    Anticancer Res; 2015 May 12; 35(5):2873-80. PubMed ID: 25964570
    [Abstract] [Full Text] [Related]

  • 23. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
    Denters MJ, Deutekom M, Bossuyt PM, Stroobants AK, Fockens P, Dekker E.
    Gastroenterology; 2012 Mar 12; 142(3):497-504. PubMed ID: 22108194
    [Abstract] [Full Text] [Related]

  • 24. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.
    Grobbee EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, Mallant-Hent RC, Lansdorp-Vogelaar I, Bossuyt PMM, Kuipers EJ, Dekker E, Spaander MCW.
    Clin Gastroenterol Hepatol; 2020 Mar 12; 18(3):667-675.e1. PubMed ID: 31419575
    [Abstract] [Full Text] [Related]

  • 25. Participation, yield, and interval carcinomas in three rounds of biennial FIT-based colorectal cancer screening.
    Stegeman I, van Doorn SC, Mundt MW, Mallant-Hent RC, Bongers E, Elferink MA, Fockens P, Stroobants AK, Bossuyt PM, Dekker E.
    Cancer Epidemiol; 2015 Jun 12; 39(3):388-93. PubMed ID: 25910865
    [Abstract] [Full Text] [Related]

  • 26. Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT).
    Breekveldt ECH, Toes-Zoutendijk E, de Jonge L, Spaander MCW, Dekker E, van Kemenade FJ, van Vuuren AJ, Ramakers CRB, Nagtegaal ID, van Leerdam ME, Lansdorp-Vogelaar I.
    BMC Gastroenterol; 2023 Feb 22; 23(1):45. PubMed ID: 36814185
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Diagnostic performance of quantitative fecal immunochemical test in detection of advanced colorectal neoplasia].
    Lu M, Chen HD, Liu CC, Zhang YH, Wei LP, Lyu ZY, Ren JS, Shi JF, Zou SM, Li N, Dai M.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec 10; 41(12):2104-2111. PubMed ID: 33378824
    [Abstract] [Full Text] [Related]

  • 31. Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT-based CRC screening program.
    Breekveldt ECH, Toes-Zoutendijk E, van de Schootbrugge-Vandermeer HJ, de Jonge L, Kooyker AI, Spaander MCW, van Vuuren AJ, van Kemenade FJ, Ramakers C, Dekker E, Nagtegaal ID, van Leerdam ME, Lansdorp-Vogelaar I.
    Int J Cancer; 2023 Apr 15; 152(8):1536-1546. PubMed ID: 36444504
    [Abstract] [Full Text] [Related]

  • 32. A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening.
    Grobbee EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, Mundt MW, Spijker WJ, Bongers EJC, Kuipers EJ, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Spaander MCW.
    Gut; 2017 Nov 15; 66(11):1975-1982. PubMed ID: 27507905
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The Diagnostic Performance of Fecal Immunochemical Tests for Detecting Advanced Neoplasia at Surveillance Colonoscopy.
    Berwald G, Young GP, Cock C, Bampton P, Fraser R, Symonds EL.
    Clin Gastroenterol Hepatol; 2024 Apr 15; 22(4):878-885.e2. PubMed ID: 37743036
    [Abstract] [Full Text] [Related]

  • 35. Faecal haemoglobin concentration is related to detection of advanced colorectal neoplasia in the next screening round.
    Digby J, Fraser CG, Carey FA, Diament RH, Balsitis M, Steele RJ.
    J Med Screen; 2017 Jun 15; 24(2):62-68. PubMed ID: 27370211
    [Abstract] [Full Text] [Related]

  • 36. Incidence of Interval Colorectal Cancer After Negative Results From First-Round Fecal Immunochemical Screening Tests, by Cutoff Value and Participant Sex and Age.
    Toes-Zoutendijk E, Kooyker AI, Dekker E, Spaander MCW, Opstal-van Winden AWJ, Ramakers C, Buskermolen M, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, Velthuysen MF, Thomeer MGJ, van Veldhuizen H, van Ballegooijen M, Nagtegaal ID, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I, Dutch National Colorectal Cancer Screening Working Group.
    Clin Gastroenterol Hepatol; 2020 Jun 15; 18(7):1493-1500. PubMed ID: 31442598
    [Abstract] [Full Text] [Related]

  • 37. Attendance and yield over three rounds of population-based fecal immunochemical test screening.
    Kapidzic A, Grobbee EJ, Hol L, van Roon AH, van Vuuren AJ, Spijker W, Izelaar K, van Ballegooijen M, Kuipers EJ, van Leerdam ME.
    Am J Gastroenterol; 2014 Aug 15; 109(8):1257-64. PubMed ID: 24980879
    [Abstract] [Full Text] [Related]

  • 38. Feasibility and Colonoscopy Yield Using the Fecal Immunochemical Test (FIT)-Based Colorectal Cancer Screening in a Latin America Country.
    Sorbello MP, Ribeiro Júnior U, Eluf-Neto J, Pfuetzenreiter V, da Silva E Sousa Júnior AH, Kawaguti FS, Cohen DD, de Mello ES, Nahas SC, Safatle-Ribeiro AV.
    Clin Gastroenterol Hepatol; 2024 Aug 15; 22(8):1719-1727.e1. PubMed ID: 38342277
    [Abstract] [Full Text] [Related]

  • 39. Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.
    Guimarães DP, Fregnani JH, Reis RM, Taveira LN, Scapulatempo-Neto C, Matsushita M, Silva SRM, Oliveira CZ, Longatto-Filho A, Eklund C, Paloheimo L, Mauad E, Suovaniemi O, Syrjänen K.
    Anticancer Res; 2019 Jan 15; 39(1):261-269. PubMed ID: 30591467
    [Abstract] [Full Text] [Related]

  • 40. Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.
    Toes-Zoutendijk E, van Leerdam ME, Dekker E, van Hees F, Penning C, Nagtegaal I, van der Meulen MP, van Vuuren AJ, Kuipers EJ, Bonfrer JMG, Biermann K, Thomeer MGJ, van Veldhuizen H, Kroep S, van Ballegooijen M, Meijer GA, de Koning HJ, Spaander MCW, Lansdorp-Vogelaar I, Dutch National Colorectal Cancer Screening Working Group.
    Gastroenterology; 2017 Mar 15; 152(4):767-775.e2. PubMed ID: 27890769
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.